mAb Medical
Safety/Pharmacovigilance

Because mAb Patient Safety Requires Focused Oversight mAb Medical Safety
and Pharmacovigilance

When medical safety expertise is critical and in-house capacity is limited, we serve as a trusted extension of your team, bringing the leadership, scale, and judgment needed to move mAb programs forward with confidence.

 

Phase 1/2:

Proactive signal detection, risk characterization, risk mitigation strategies, and communication for mAb programs.

Phase 3/Post-Authorization

We drive Phase III and post-approval safety oversight for mAb programs that de-risk development, satisfy regulators, and protect patients.

Pharmacovigilance

We drive global, inspection-ready safety across the mAb product lifecycle, combining compliant case management, blinded oversight, strong governance, and rapid regulatory response to de-risk development and enable your science to scale with growth.

Our teams combine strategic insight with hands-on execution to deliver medical safety solutions that support confident decision-making, regulatory success, and sustainable mAb product growth.

 

Get Started Advance Your Drug Program
with Confidence

Start building reliable, high-quality drug development programs today.